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ABSTRACT 
SPERM MITOCHONDRIAL COPY NUMBER AND ASSOCIATIONS WITH 
OXIDATIVE STRESS AND PHTHALATE METABOLITES IN MALE PARTNERS 
UNDERGOING ASSISTED REPRODUCTIVE TECHNOLOGIES 
MAY 2017 
ALEXANDRA M. OLMSTED, B.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Professor J. Richard Pilsner 
 
INTRODUCTION 
Phthalates, a chemical class of plasticizers, are ubiquitous in the environment and recognized 
as endocrine disrupting compounds (EDCs). Recent data suggest that oxidative stress is a 
potential mediator of poor male reproductive health associated with phthalate exposure. 
Mitochondria are implicated in the production of excess oxidative stress and sperm 
mitochondrial copy number (MtCopy) and deletions (MtDeletion) have been linked with 
male infertility. However, little is known about the relationship of these mitochondrial 
biomarkers in sperm with phthalate exposure and oxidative stress.   
OBJECTIVES 
To examine associations of urinary phthalate metabolites and isoprostane concentrations on 
sperm MtCopy and MtDeletions in male partners undergoing assisted reproductive 
technologies (ART). 
METHODS 
 v  
A total of (n=97) sperm samples were collected from male partners undergoing ART at 
Baystate Medical Center, in Springfield, MA from 2014 to 2016 as part of the Sperm 
Environmental Epigenetics and Development Study (SEEDS). Seventeen urinary phthalate 
metabolites (n=103) were analyzed by the Centers for Disease Control using tandem mass 
spectrometry. 15-F2t-Isoprostane (n=101) was measured using a competitive enzyme-linked 
immonsorbent assay in urine of male individuals. A triplex Taqman probe-based qPCR 
method was developed for relative quantification of genomic DNA, MtCopy and 
MtDeletions. Multivariable linear or logistic regression was employed to examine 
associations with age, BMI, batch and current smoking status with each outcome to 
determine confounders used for adjustment. 
RESULTS 
Quartiles of MtCopy and MtDeletion were positively associated with the odds of male 
infertility (p for trend < .0001 and 0.007, respectively). Urinary metabolite concentrations of 
MCNP displayed a positive association with MtCopy (β=1.56; p =0.03).  Urinary MEHP 
concentrations were positively associated with MtDeletion in only infertile individuals 
(n=30) (β = 0.075; p = 0.006). Urinary isoprostane concentration was not associated with 
MtCopy or MtDeletion, but was associated with seven phthalate metabolite concentrations 
(MEOHP, MEHHP, MBzP, MHBP, MiBP, and MHiBP). 
CONCLUSIONS 
To our knowledge, this is the first study to investigate the relationship between sperm 
MtCopy and MtDeletion with oxidative stress and phthalates. These results suggest that 
certain phthalate metabolites may be associated with a known biomarker of systemic 
oxidative stress. Sperm mitochondrial function as measured by MtCopy and MtDeletion may 
 vi  
be considered biomarkers of male infertility, although no relationship was shown between 
mitochondrial outcomes and oxidative stress. Future research is investigating these 
relationships with developmental outcomes including embryo quality. 
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CHAPTER 1 
INTRODUCTION 
1.1. Introduction to Endocrine Disrupting Compounds 
An endocrine disrupting compound is defined by the Endocrine Society as “an 
exogenous [non-natural] chemical, or mixture of chemicals, that interferes with any aspect of 
hormone action” (Gore AC et al., 2014). In the body, hormones are naturally produced within 
glands that travel throughout the body and bind to specific receptors to trigger a response 
(Gore AC et al., 2014). Endocrine disrupting compounds have been shown to act similarly to 
the body’s naturally produced hormones and bind with androgen and estrogen receptors in 
the body. Associations between a number of different identified EDCs and human health 
issues have emerged as a major public health issue. Due to the nature of the endocrine 
system, even endogenous hormones function at levels in the picomolar and nanomolar range 
(Vandenberg LN et al., 2012). Environmentally relevant doses of EDCs have been associated 
with adverse health effects (Attina TM et al., 2016). Low chronic doses of an EDC, or one of 
its metabolites, have the ability to bind with receptors and alter estrogen or androgen-
dependent gene expression by acting as an endogenous hormone. Even disruption of that 
compound at a relatively few number of receptors may trigger a physiological change 
(Vandenberg LN 2012).  
 
1.2. Male Infertility and Reproductive Health 
In 1992, it was suggested that sperm counts had declined by over 50% during the second 
half of the last century (Carlsen et al., 1992). General fertility as measured by births per 1000 
women aged 15-44 in 2010 was 37% lower than in 1950 (Damario MA 2014). While about 
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half of all cases of infertility are attributed to the male partner, recent estimates suggest 
defective sperm occurs in approximately 5% of all individuals (Aitken RJ et al. 2014; JM 
Cambell et al 2015). Such declines have even been observed in donated sperm from males 
living in Massachusetts region including disturbances in sperm count and motility between 
2003 to 2013 (Centola GM et al. 2016). As these estimates have risen, so have increases in 
testicular cancer (Purdue MP et al. 2005) and sex organ malformations (Aitken RJ et al. 
2004) in humans over the past decades. Of particular relevance, testicular dysgenesis 
syndrome (TDS) is considered the disorder related to in utero endocrine disrupting chemical 
exposure and associated with disturbances in male development and affect fertility (te Velde 
E et al. 2001). Men with poor quality semen parameters have been shown to have a higher 
risk for other diseases including testicular cancer (Hanson HA et al 2016). Investigation of 
semen quality parameters indicate their use in determination of overall health. A large study 
of 43,277 men found an inverse relationship between the percentage of morphologically 
normal and motile spermatozoa with mortality (Jensen TK et al 2009). Fertility status may 
therefore be useful in evaluating overall men’s health. 
There has been increasing desire for the use of assisted reproductive technologies (ART) 
in the United States (Stephen EH et al. 2015). Recently, it has become evident that a variety 
of developmental outcomes in progeny are related to the health status of the male fathers 
undergoing ART (Eisenberg ML et al 2016). Additionally, adverse developmental outcomes 
have been found in association with various adverse developmental outcomes (Smarr MM et 
al., 2015). In humans, preconceptive paternal exposures including tobacco products (Sapra 
KJ et al., 2016), persistent organic pollutants (Robledo CA et al., 2015), and bisphenol A and 
phthalates (Buck Louis et al., 2014) have been shown to be associated with birth size 
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(Robledo CA et al., 2015), longer time to pregnancy (Sapra KJ et al. 2016), and decreased 
fecundity (Buck Louis et al 2014). Additionally, paternal preconceptive exposures have been 
shown to contribute to birth outcomes in couples using ART (Dodge LE et al. 2015). In our 
SEEDS population, paternal urinary concentrations of four phthalate metabolites were 
inversely associated with high-quality blastocysts at the blastocyst stage (Wu H et al., 2017). 
A number of studies have investigated birth and disease outcomes in association with the use 
of ART, although the extent to which preconception paternal exposure contributes to 
developmental outcomes remains undetermined.  
 
1.2.1. Specific Times of Vulnerability to Male Germ Cell 
The period of preconception has been increasingly recognized as an early window of 
susceptibility of human development to environmental exposures. In its maturation process 
from diploid to haploid called spermiogenesis, the male germ cell develops over a period 
estimated to be 74 days in humans (Wu H et al 2015).  During maturation, repair mechanisms 
and apoptosis in response to damage are limited. Additionally, protection by the Sertoli cells 
is lost as sperm formed in the epididymis continue along the male reproductive tract (Aitken 
et al. 2004). Although mechanisms of repair are in place to handle sperm abnormalities, at 
multiple time points after maturation the sperm can undergo changes that may alter their 
ability to fertilize.  
 
1.3. Phthalates 
Phthalates diesters are a class of synthetic organic chemicals used in industrial and 
consumer products. HMW phthalate products include uses in flexible vinyl plastics, medical 
 4  
equipment, food packaging, and building materials such as flooring and wallboard. 
Applications of LMW phthalates are typically included in personal care products, and 
insecticides as solvents, fixatives, or alcohol denaturants (Johns LE 2015; ATSDR 1995, 
2001; Zota AR et al 2014). Exposure routes typically include ingestion, inhalation, and 
dermal absorption (Zota AR et al. 2014). Phthalate diesters are quickly metabolized to their 
monoester form in the body. Measurement of phthalate metabolites have been found in urine 
in sampling of the U.S population, of all ages, and worldwide (CDC, 2015). Acting similarly 
to phthalates, newer phthalate alternatives may also have the potential to impact human 
health, such as the parent compound DINCH. Phthalates are not covalently bond to products 
and are therefore easily released into the environment (Meeker JD et al. 2009). 
Biomonitoring data in the U.S from 2001-2010 have highlighted recent temporal changes in 
the exposure profiles of phthalates found in urine. Since high molecular weight parent 
phthalates have been found in association with reproductive health outcomes, alternative 
phthalates such as DINCH have emerged in an effort to replace those with potential adverse 
effects on human health (Zota AR et al. 2014).  
 
1.3.1. Phthalates and Male Reproductive Health 
Although some parent phthalates have been banned, much is left unknown about the 
alternative compounds that have taken their place. Exposure to phthalates has been 
associated with a number of poor health outcomes, including reproductive health. Formed 
during hydrolytic and oxidative metabolic steps, the monoesters of the diester parent 
compounds are believed to be responsible for toxicity (Lioy PJ et al., 2015). In humans, 
phthalate exposure has the ability to disrupt the male reproductive system as evidenced by 
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alteration of anogenital distance (Suzuki Y et al. 2012; Swan SH et al. 2015), sex steroid 
hormone synthesis (Meeker JD et al. 2009), serum testosterone (Meeker JD and Furguson 
KK 2014), sperm motility and concentration (Pant N et al 2014; Cai H et al. 2015), and by 
sperm DNA damage (Hauser R et al. 2007). In addition to evidence in epidemiologic 
findings, findings of phthalate exposure and male reproductive outcomes in animal models 
include reduced sex organ weight (Shono T et al. 2014), abnormal Leydig cell aggregation 
(Mahood IK et al. 2007), repression of sex determination (Wang YX et al. 2015), altered sex 
ratio (Dobrynska MM et al. 2011) and delay in sexual maturity (Lee KY et al 2004). In 
animal models, “phthalate syndrome” is used to describe adverse male reproductive health 
outcomes due to androgen deficiency resulting from exposure to different parent phthalates 
(Lioy PJ et al., 2015).  Taken together, an estimated 240,100 cases of male infertility 
resulting in the use of ART are reasoned to be due to Benzylphthalates (BBzP) and 
butylphthalates (DBP) in males aged 20 to 39 in the United States. In addition, early 
mortality attributed to phthalates and low testosterone in men aged 55 to 64 is estimated to be 
10,700 cases in the United States (Attina TM et al 2016).  
 
1.4. Oxidative Stress 
Oxidative stress is characterized by the disruption of redox signaling and control 
(Jones DP 2006). By endogenous and exogenous mechanisms of production of free radicals, 
oxidative stress in the body can be triggered in the presence of a variety of chemical 
compounds (Klaassen and Watkins 2010). Physiologically necessary as a major signaling 
mechanism of intracellular proteins, the redox balance of prooxidant and antioxidants is 
required for normal energy homeostasis in the body. Oxidative stress has been implicated in 
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various diseases, including cancer and neurodegenerative disorders as well as male infertility 
(Sedha S et al. 2015). Oxidative stress may cause lipid peroxidation and DNA fragmentation 
to disrupt male fertility, although the mechanisms are not fully understood. A variety of 
pathological outcomes by oxidative stress result from increases in reactive oxygen species 
(ROS) or decreases in antioxidant defense mechanisms.  
 
1.4.1. Phthalates and Oxidative Stress 
Oxidative stress has been considered a potential mediator in phthalate-associated 
reproductive outcomes. Several parent phthalate compounds have been implicated in 
contributing to oxidative stress conditions by increasing ROS. Evidence of ROS induction in 
human sperm has been shown in the parent compound DEHP and its metabolites in polyvinyl 
workers, in addition to increased sperm apoptosis (Huang LP et al. 2014). The induction of 
ROS was also shown by DEHP in human endometrial cells (Cho YJ et al. 2015). Phthalates 
form hydroperoxides during their metabolism which have been shown to induce enzymes 
responsible for antioxidation such as superoxide dismutatase (SOD) and GPx in animal 
models (Agus HH et al., 2015). Similarly, those enzymes may become depleted and the body 
may lose its ability to utilize this defense. In rats, treatment with DBP has been shown to 
decrease testicular antioxidant enzymes (Aly HA, et al. 2016). Another study using a rodent 
model, showed that MEHP, a metabolite of DEHP, increased superoxide generation and 
resulted in decreased ATP production (Savchuk I et al., 2015). Additionally, mounting 
evidence suggests that there are strong positive associations between urinary phthalate 
concentrations and biomarkers of oxidative stress among pregnant women (Ferguson KK et 
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al. 2014; Ferguson KK et al. 2015), both partners of couples planning pregnancy (Guo Y et 
al. 2014), as well as among the general US population (Ferguson KK et al. 2012). 
 
1.4.2. Mitochondria and Relation to Oxidative Stress 
Mitochondria are responsible for energy-production in a cell. The circular, haploid 
mitochondrial genome is 16kb in length and encodes 37 genes of which 13 are necessary for 
the electron transport chain (Chen X et al., 2012). Mitochondria are connected to most ROS 
production in the cell from leakage from the Electron Transport Chain. In most cells, 95% of 
all free radical formation is due to this (Malik AN and Czajka A 2013). In sperm, 
mitochondria are responsible for cellular energy production (ATP) necessary for their 
motility and function (Gabriel MS et al. 2012) and form around the midpiece of the flagella 
to form tight helix and allow propulsion (May-Panloup P et al., 2003).  In addition, its other 
roles include production steroid hormone, generation of FeS clusters, ion homeostasis, and 
apoptosis (Demain LA et al 2016). Different cell types have been shown to have different 
MtCopy, or number of copies of mitochondrial DNA (Phillips NR et al 2013). Additionally, 
the mitochondrial genome may be susceptible compared to the nuclear genome due to its lack 
of protective defenses such as histones, antioxidant containing cytoplasm, and DNA repair 
mechanisms (Sutovsky P et al 2003).  
Production of mitochondria can be triggered in situations where ROS have 
overwhelmed its ability antioxidant system.  Reactive oxygen species may overwhelm an 
antioxidant system dealing with an oxidative stress to trigger production of mitochondria 
(Zhong J et al. 2015). The relationship between mitochondrial abundance, as measured by the 
ratio of mitochondrial DNA to nuclear DNA copy number, has been shown to be elevated in 
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situations of oxidative stress in human leukocytes (Liu CS et al., 2003) however this 
relationship is unknown in sperm. Mitochondrial copy number (MtCopy) is recognized as the 
copies of MtDNA per spermatozoan and can be calculated using a target nuclear gene in 
comparison to a nuclear single-copy gene. Mitochondrial copy number has been recognized 
as a potentially useful biomarker of oxidative stress in humans. Increased copy number, or 
mtDNA per spermatozoon, can result from a feedback responsive representative of defective 
fragmented or mutated mtDNA (Lee HC et al. 2000). Defected mitochondria are often 
proliferated (Andreu AL et al., 2009) and aborted apoptosis or abnormal spermatogenesis 
may result in an increased copy number (Song GJ and Lewis V, 2008). When normal 
biogenesis and degradation are not controlled by normal signaling processes under conditions 
of oxidative stress, the processes that control the accumulation of damaged mitochondria 
such as fission and mitophagy may result in and excess production of free radicals. The DNA 
of these mitochondria may become further damaged by deletions or mutations which is in 
close proximity to the excess ROS being generated (Malik AN and Czajka A 2013). 
Because mitochondrial DNA elimination is expected to occur throughout sperm 
maturation, low copy numbers are expected in normal sperm of men. A number of different 
studies have shown that MtCopy is higher in sperm of infertile men, including those with 
abnormal semen parameters. Using different methods, elevated mitochondrial copy number 
per haploid genome has been found in association with poor sperm motility (MS Gabriel 
2012), male infertility (Song and Lewis 2008, May-Panloup et al. 2003), and differential 
global and gene-specific sperm DNA methylation (Tian M et al 2014). Additionally, 
mitochondrial integrity has been shown to have inverse associations with semen parameters 
(Song and Lewis, 2008). To investigate mitochondrial integrity, it is useful to measure a 
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target sequence within an area known for its common deletions in reference to a sequence 
region in the mitochondrial genome not known to have any deletions. 
 
1.4.3. Isoprostane as a Biomarker of Oxidative Stress 
Isoprostane is one commonly used measure of oxidative stress in vivo (Kadiiska et al 
2005; Roberts LJ and Morrow JD 2002). In biomembranes, poly-unsaturated fatty acids, such 
as arachidonic acid, are especially susceptible to insults of free radicals caused by conditions 
of oxidative stress. F-2 isoprostanes are prostaglandin-like compounds formed 
nonenzymatically on lipids by the autoxidation reaction between arachidonic acid and 
oxygen to produce free radicals. Lipid peroxidation is well-recognized mechanisms in which 
free radicals may cause harm to a system and lead to pathogenic injury and disease (Jacob 
KD et al 2013). Because of the high amount of unsaturated fatty acids in spermatozoa, they 
are considered highly susceptible to lipid peroxidation (RJ Aitken et al 2014).  
Some isoprostanes are biologically potent and may they themselves lead to 
pathogenic injury, although this has not been determined for all isoprostanes.  In the presence 
of hydrolyzing enzymes, isoprostane may be more present in its more bioactive form as free 
acid than as estrified isoprostane. Isoprostane may be formed ex vivo in the presence of lipids 
and therefore urine may be the most biologically accurate marker in part due to their low 
lipid levels compared with other biological fluids (Roberts LJ and Morrow JD 1997). 
Additionally, under proper storage conditions isoprostanes are stable. Spot urine samples 
throughout the day and over a 24-hour period show considerable correlation (S Basu, 2008). 
In urine, isoprostanes are recognized for their ability to indicate systemic oxidative stress. 
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1.4.4. Oxidative Stress and Impact on Fertility 
A conceivable pathway in which phthalate exposure may lead to oxidative stress is 
shown in Figure 1. From publications, there is an indication that increases of ROS are related 
to phthalates and therefore increased systemic oxidative stress, and phthalates are associated 
with poor male reproductive health outcomes. Additionally, the literature suggests increases 
in MtCopy and MtDeletion are indications of damaged MtDNA and are associated with male 
infertility in sperm. Figure 1 shows a conceivable pathway by which phthalates impact 
MtCopy and MtDeletion resulting in sperm damage. Both systemic oxidative stress and 
sperm MtCopy and MtDeletion could be mediators in the relationship between phthalate 
exposure and sperm damage. To our knowledge, the relationship between sperm MtCopy and 
MtDeletion and isoprostanes and with phthalates has yet to be investigated. 
 
Figure 1. Conceptual Diagram. Image represents a potential for phthalate exposure to 
affect sperm quality and impact mitoch. 
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CHAPTER 2 
PROJECT RATIONALE 
2.1. Project Rationale 
The extent of this research thesis covers three main objectives. The first objective of 
this research is the design of a TaqMan probe based qPCR triplex for use in simultaneously 
quantifying mitochondrial copy number (MtCopy) and mitochondrial deletion (MtDeletion) 
of sperm. The second objective is to analyze our findings of sperm MtCopy with urinary 
phthalate metabolites of individuals enrolled in the Sperm Epigenetics and Development 
Study (SEEDS) to examine associations. The third objective is to examine associations 
between a known systemic biomarker of oxidative stress, urinary 15-F2t- Isoprostane, with 
sperm MtCopy and MtDeletion. In addition to these findings other relationships with subsets 
of the SEEDS population will be considered, including stratified analyses based on smoking 
and infertility status.  
 
2.2. Hypothesis Statement 
For the first aim of this thesis, we hypothesis that the three targets can be used in one 
simultaneous reaction to accurately measure MtCopy and MtDeletion in each human sperm 
sample. Secondly, using statistical analyses and qPCR generated data for MtCopy and 
MtDeletions, we hypothesis that MtCopy and MtDeletions will be positively associated with 
phthalate metabolites. Lastly, we hypothesize that the biomarker of oxidative stress, 
isoprostane, will be positively associated to MtCopy and MtDeletion in our population.  
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CHAPTER 3 
METHODS AND MATERIALS 
3.1. Study Population 
The first 103 individuals were chosen as part of a prospective cohort based out of 
Baystate Medical Center Fertility Clinic in Springfield, Massachusetts. All participants 
undergoing assisted reproductive technologies (ART) voluntarily provided clinic information 
and specimens to the hospital to be used as part of the Sperm Environmental Epigenetics and 
Development Study (SEEDS). Inclusion criteria for male participants include being 18-55 
years of age using one’s own gametes for ART and providing written consent to physicians. 
Institutional review boards at Baystate Medical Center, the University of Massachusetts 
Amherst, and the Centers for Disease Control and Prevention (CDC) authorized this study. 
 
3.2. Sperm Preparation 
3.2.1. Procurement and Isolation 
Remaining sperm after IVF were used from all volunteers after a two-day period of 
abstinence. All samples were collected fresh on day of oocyte retrieval. Semen was purified 
to sperm pellets by gradient centrifugation and RLT Buffer and TCEP were added to 
preserve DNA and RNA. 
 
3.2.2. DNA Extraction 
Total genomic and mitochondrial DNA was extracted from isolate sperm using 
QuiAMP DNA Mini Kit (Qiagen) via method by Wu H et al. 2015. Samples were either used 
fresh or stored in -80oC.  
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3.3. qPCR 
3.3.1 Primer and Probe Design and Sequences 
Primers and probes were chosen based on amplification efficiency and R2 values. 
MinorArc was chosen as the mitochondrial target for use of derivation of copy number due to 
similar efficiencies with other targets observed in tested reactions. In order to regard possible 
interactions, all reactions were performed in combinations of singleplex and duplex before 
being run in Triplex. Additionally, all reactions were tested in 10ul per well and 20ul per 
well. The following Table 1 shows the sequences used for this assay. 
Table 1. Primer and Probe Sequences for qPCR. Labeled sequences (Phillips NR et al. 2014) 
for use in Triplex. 
 MinorArc MajorArc 
FWD 
Primer 
5’- CTA AAT AGC CCA CAC GTT CCC-3’ 5’-CTG TTC CCC AAC CTT TTC CT-3’ 
REV 
Primer 
5’- AGA GCT CCC GTG AGT GGT TA-3’ 5’-CCA TGA TTG TGA GGG GTA GG-3’ 
Probe 6FAM-CAT CAC GAT GGA TCA CAG GT-
MGBNFQ 
NED- GAC CCC CTA ACA ACC CCC-
MGBNFQ 
 
3.3.2. Sperm Dilution 
In order to maintain ~10ng/ul as a concentration, sperm genomic DNA were tested on 
NanoDrop 2000/2000c Spectrophotometer (Thermo Scientific) and diluted to ~5ng/ul using 
the formula C1V1=C2V2. If sample was below 5ng/ul, no dilution was performed. 
 
3.3.3. Assay Reagents 
Dilution of stock concentrations was performed for MinorArc Primers, MinorArc 
probes, MajorArc primers, and MajorArc probes. The aforementioned were diluted to 5uM 
with TE Buffer pH 8.0 from their stock concentrations of 100uM. See Appendix I for Pilsner 
Lab Protocol for Relative Quantification. The following Table 2 shows reagents the volume 
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and concentrations of each reagent used in the assay following dilution from stock 
concentrations. 
   Table 2. Reagents used in each 10ul volume well. 
Reagents Volume  
FAM labeled MinorArc Probe at 5uM 0.5uL 
MinorArc Primer Mix at 5uM 0.5uL 
NED labeled MajorArc Probe at 5uM 0.5uL 
MajorArc Primer Mix at 5uM 0.5uL 
VIC labeled RNAseP Primer/Probe Mix at 20x 0.5uL 
Nuclease-free H2O 0.5uL 
ProAmp 2x Master Mix 5uL 
~5ng/ul DNA template 2uL 
 
TaqMan probes were used for both mitochondrial targets and the nuclear target. 
According to ThermoFisher Scientific, the use of fluorescent probes allow for high 
reproducibility and sensitivity and assessment of low copy number variation. The choice was 
two mitochondrial targets in this triplex was modified based on previous findings (Phillips 
NR et al. 2014) for use with sperm. The MinorArc genomic sequence used in this assay is 
located in the D-Loop where deletions have not been reported, and primer and probe target 
regions are free of polymorphic sites. In addition, MinorArc was chosen, as opposed to other 
mitochondrial targets tested, due to its lack of interaction with other targets and high 
amplification efficiency. The MajorArc target used in this assay contains the “common” 
deletion, recognized as a 4977 bp area with observed large deletions in humans with 
mitochondrial syndromes (Moraes CT et al 1989), Alzheimer’s Disease (Corral-Debrinski M 
et al 1994), ALS (Keenery PM and Bennett JP 2010), and prostate cancer (Reguly B et al. 
2010) in somatic cells. Within our target region, our target spans about 84% of the known 
Major Arc deletions (Phillips NR et al. 2014). RNAseP is a well-established nuclear 
reference gene present in two copies in a diploid genome and has been designed by 
ThermoFisher to serve as their recommended copy number reference assay in humans. 
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Similarly, the ProAmp Taq Master Mix chosen was chosen based on its use in qPCR with 
multiple targets and its use with copy number quantification. 
 
3.3.4. qPCR Conditions 
Conditions for activation and extension were based on Master Mix recommendations. 
Annealing temperature of 55oC was used based on previous findings for this primer set and 
checked by standard curve. The following conditions were used: 95oC for 10 minutes 
activation, 95oC for 15 seconds, 55oC for 15 seconds and 60oC for 60 seconds. 
 
3.3.5. Amplification Efficiency 
The linearity and slope of the three targets across standards was used to verify their 
respective acceptable amplification efficiencies. The standard curve was plotted with average 
CT of triplicate wells for each target on the Y-axis and log DNA added to each reaction on 
the X-axis. Trend line was added to series of each target across standards as well as adding 
R2 values. R2 values are considered acceptable at values greater or equal to 0.99.  The 
amplification efficiencies of each target may be calculated using the slope of each trend line 
across standards. The formula for efficiency of each target is calculated by the following 
formula: E=10^(-1/slope), where the slope is calculated across all standard. Amplification 
efficiencies are considered acceptable between 90-105%.  
 
3.4. Copy Number and Integrity Derivation 
3.4.1. Choice of Wells 
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CT differences across triplicate samples which yield a standard deviation of >0.5 for 
any one target were evaluated to determine which of the three wells should be eliminated, at 
which time only duplicate measurements will be used. Duplicate measurements were used in 
seventeen instances across all plates. Linearity and slope were used to regard amplification 
efficiencies and R2 values for all targets on all plates for six-point standard curve. 
 
3.4.2. Derivations of Mitochondrial Copy and Deletion 
For each reaction per the following formula was used to determine mitochondrial 
copy (MtCopy): 2^(meanCT), where CT=(RNAseP CT- MinorArc CT). Similarly, the 
formula used for mitochondrial deletions (MtDeletions): 2^(meanCT), where 
CT=(MinorArc CT- MajorArc CT). CT differences are found per reaction and averages 
were based on CTs from triplicate measurements. Coefficients of variation for calculated 
copy numbers on each plate were <10%. 
 
3.4.3. Validation Using Digital PCR 
To validate our qPCR method, we measured eight repeated samples on a digital PCR 
machine (QuantStudio 3D Digital PCR System), which provides absolute concentrations 
(ThermoFisher Scienfic). 
 
3.5. Urinary Phthalate Measurement 
3.5.1. Sample Procurement and Storage 
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Urine analyses of phthalates were performed from a spot urine sample from SEEDS 
participants. Urine was collected in a sterile polyproplyene cup on the same day as the semen 
sample, vortexed, separated into 10 ml aliquots, and frozen at -80ᵒC at UMass Amherst.  
 
3.5.2. Measurement of Urinary Phthalate Metabolites 
All urine specimens were shipped to the CDC on dry ice. Measurement of seventeen 
different urinary phthalate metabolites was performed by the Centers for Disease Control 
using enzyme deconjugation, solid-phase extraction, and tandem mass spectrometry as 
described (Kato et al. 2005). The following seventeen urinary phthalate metabolites were 
analyzed: Mono(2-ethylhexyl) phthalate (MEHP); Mono(2-ethyl-5-hydroxyhexyl) phthalate 
(MEHHP); Mono(2-ethyl-5-oxohexyl) phthalate (MEOHP); Mono(2-ethyl-5-carboxypentyl) 
phthalate (MECPP); Monocarbxyisooctyl phthalate (MCOP); Mono-isononyl phthalate 
(MNP); Monobenzyl phthalate (MBzP); Mono (3-carboxypropyl) phthalate (MCPP); 
Monocarboxy-isononly phthalate (MCNP); Mono-n-butyl phthalate (MBP); Mono-3-
hydroxybutyl phthalate (MHBP); Mono-isobutyl phthalate (MiBP); Mono-hydroxyisobutyl 
phthalate (MHiBP); Mono-ethyl phthalate (MEP); Mono-methyl phthalate (MMP); 
cyclohexane-1,2-dicarboxylic acid-monocarboxy isooctyl ester (MCOCH); and cyclohexane-
1,2-dicarboxylic acid-mono(hydroxy-isononyl) ester (MHiNCH). One phthalate metabolite 
(MMP) was not performed on the second batch of measurement by the CDC. Limits of 
detection (LOD) varied between batches and ranged from 0.1 to 0.9 ng/mL across all 
metabolites. Values falling under the LOD for each metabolite on each plate were 
transformed to become the LOD/ 2. Parent phthalate and phthalate alternative diester 
chemical structures and formulas of the above metabolites are included in Appendix II. 
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3.5.3. Dilution Correction and Log Transformation 
Specific gravity was measured in urine by the CDC or by Baystate Reproductive 
Clinic using a handheld refractometer for participants (Atago Co., Ltd., Toko, Japan). The 
formula for dilution normalization of phthalate measurement by specific gravity is 
Pc=P[(SGm-1)/(SG-1)] where SGm is the median SG value of all samples, SG is the specific 
gravity value for that individual urine samples, and P is the measured phthalate metabolite 
concentration. Values were log transformed for analyses.  
 
3.6. Urinary 15-F2t-Isoprostane 
3.6.1. Sample Preparation 
A competitive enzyme-linked immunoassay was used to measure urinary 15-F2t 
isoprostane of 102 samples (Cat#: EA84, Oxford Biomedical Research). In preparation of 
urine, -glucuronidase was added to each sample and heated for two hours at 37oC as a 
pretreatment to dilution. The purpose of this step is to allow for more free isoprostane which 
has been found to be conjugated as glucuronic acid (>50%) (Yan Z et al. 2010) so treatment 
allows for higher extraction of 15-F2t-IsoP. As per protocol, 5ul of glucuronidase was added 
for every 100ul of urine. Samples were then diluted with kit’s dilution mix. Dilution factors 
were dependent on specific gravities of each sample, with most having a dilution factor of 5. 
15-F2t-isoprostane conjugated horseradish peroxidase competes on the antibody encoded 96-
well microplate with 15-F2t-isoprostane in each sample. Intensity can be read after adding 
TMB substrate and sulfuric acid. The limit of detection is 0.2ng/mL. In addition, two control 
samples were run on all plates.  
3.6.2. Concentration Quantification 
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A seven-point standard curve was run in duplicate with known stock standard. 
Additionally, a Reagent Blank (RB) with no conjugate, and a B0 containing no sample or 
standard were performed in duplicate. The calculation of 15-isoprostane F2t was performed 
using the manufacturer’s calculation template, where duplicate well absorbance values were 
taken. Samples with CV>15% were repeated. Each plate was read twice on a SpectraMax M2 
microplate reader (Molecular Devices). A Solver add-in program for Excel was used to fit 
the standard curve concentrations to find the percent of maximum binding (Frontline Solver). 
For each sample, the average the RB was subtracted from the average OD between 
duplicates. That value was divided by the percent of maximum binding (%B/B0) which was 
achieved by solving the function using each actual standard versus the predicted value. All 
values were then corrected for dilution using their specific gravities as previously mentioned 
for phthalates. 
 
3.7. Statistical Analyses 
To examine the distributions of SG-corrected phthalate metabolites and isoprostane 
concentration, geometric means were taken in addition to selected percentiles. Pearson 
correlation was achieved to examine the relationship between MtCopy numbers derived from 
digital PCR and qPCR. A Welsh two-sample t-test was used to determine if phthalate 
metabolites, isoprostane, and mitochondrial endpoints were significantly different between 
fertile and infertile men.  Generalized linear regression models (GLM) were used to examine 
the relationship between MtCopy and MtDeletion with different phthalate metabolites and 
isoprostane. Additionally, GLM were used to assess the relationship between phthalate 
measurements with urinary isoprostane. Covariates were chosen based on biological 
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plausibility or those found in bivariate analyses to be associated with phthalate metabolites, 
isoprostane, or mitochondrial outcomes. Included covariates used in adjusted analyses were 
age, BMI, current smoking, batch phthalate, and batch mitochondrial target. Current smoking 
was determined using a Cotinine ELISA kit (Calbiotech Cat#: CO096D). To further explore 
differences between individuals classified with male factor infertility and those without, 
stratified analyses were additionally performed. Logistic regression was used to consider the 
odds of infertility by quartile of mitochondrial outcomes (MtCopy and MtDeletion), after 
adjustment for covariates. Analyses were performed using R version 0.99.903 (R Core Team 
2016, Vienna, Austria).  
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CHAPTER 4 
RESULTS 
4.1. Triplex Standard Curve 
 Figure 2 shows a typical standard curve used in assessing efficiency in the design of 
this assay with 10ng of sperm DNA from three individuals. The three targets are shown to 
have similar amplification efficiencies within the desired range of 90-105%. Additionally, 
the R2 values are shown to be acceptable for all targets in repeated trials and therefore 
acceptable for use with SEEDS specimen (R2>0.99). 
 
 
Figure 2. Standard Curve of Triplex. qPCR CT results for three targets across log gDNA 
concentration with associated amplification efficiencies and R2. 
 
4.2. Demographic Statistics 
The study population includes males seeking fertility treatment at Baystate Medical 
Center. Table 3 outlines the breakdown of smoking, alcohol, BMI, age, race, and fertility 
status of male individuals. Data used to determine BMI, age, and fertility at time of specimen 
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collection was assessed by physicians. Individuals were determined to have male factor 
infertility by hospital staff based on 2010 WHO sperm quality 5th centile reference values 
including concentration <15 million/mL, total motility < 40% motile, and normal forms <4%. 
Alcohol and smoking usage history was determined by an optional questionnaire provided to 
each participant in the study. Percentage of no response was fairly even for childhood 
exposure to smoking, current drinking, and age of first drink (21%, 16.5%, 19.4%, 
respectively). Additionally, about 43% of participants refused to provide information on race 
or were missing questionnaire data. Current smoking was determined using a Cotinine 
ELISA kit (Calbiotech Cat#: CO096D) and eight smokers were identified. 
The average age of male partners was 35.8 9 ± 5.37 years old and the majority of 
individuals were between the ages of 30 and 40 (60%). The average BMI was 29.67 ± 6.06. 
Approximately 36% of individuals are classified as overweight (BMI between 25-29.9), 
while close to 40% of individuals could be classified as obese (BMI>30).  The study 
population is made up of approximately 29% infertile males, based on WHO guidelines. 
Approximately 51.45% of participants identify as white, although close to 43% of the 
population refused to answer or have missing data from the questionnaire. Childhood 
exposure to smoke, defined by presence of someone in the household smoking while under 
the age of 18, was 36.9% in this population. The majority of individuals identify as current 
drinkers (80.60%), and approximately 45% of the total population recorded their age of first 
drink as under 18.  
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Table 3. Population demographics of SEEDS male partners 
 
4.3. Descriptive Statistics of Metabolites 
Distribution of specific gravity adjusted urinary phthalate metabolite concentrations 
(ng/mL) for male individuals in this study are included in Table 4. Table 4 presents 
geometric means and selected percentiles of each metabolite. For twelve metabolites, the 
percentage of samples with limits of detection greater than 90% and include MEOHP, 
MEHHP, MECPP, MBzP, MBP, MHBP, MHiBP, MMP, MCOP, MEP, MCPP, and MCNP. 
For two metabolites of DINCH, a phthalate alternative, limits of detection were 38.8% for 
MCOCH, and 63.1% for MHINCH; these were among the lowest percent detected in 
addition to MNP. Highest geometric mean concentrations of urinary phthalate metabolites 
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include MEP, followed by MCOP, and MECPP.  All three of these metabolites had detection 
frequencies <90%. 
Table 4. Geometric means and selected percentiles of phthalate metabolites. Urinary 
phthalate metabolite concentrations represent male partners of SEEDS participants. 
 
4.4. Descriptive Statistics of Mitochondrial Outcomes and Isoprostane 
Figures 3 and 4 show violin plots for MtCopy and MtDeletion data, respectively. The y-axis 
represents to MtCopy number, or MtDeletion value. Inter-assay CVs for MtCopy and 
MtDeletion were 2.4% and 2.8%, and intra-assay CVs were 4.77% and 7.83%. Table 5 
presents the geometric means of MtCopy, MtDeletion, and Isoprostane (IsoP) with selected 
percentiles, where values for IsoP are expressed in ng/mL. The median and geometric mean 
of MtCopy in our population was 1.75 and 1.89, with an IQR of 1.59. For MtDeletion, the 
median and geometric mean are 0.2 and 0.17 and the IQR is 0.15. The median and geometric 
mean of isoprostane are values of 3.49 and 3.46 ng/mL, and the IQR is 1.91 ng/mL. 
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Figure 3. Violin plot of MtCopy (n=97)  
 
 
Figure 4. Violin Plot of MtDeletion (n=97)  
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Table 5. Geometric means and selected percentiles of IsoP, MtCopy, and MtDeletion. Values 
represent urinary IsoP concentration (ng/mL) and sperm MtCopy and MtDeltion 
 
4.5. Digital PCR 
 The use of digital PCR (dPCR) allows for the absolute measurement of the target 
DNA. Using two specific targets, our MinorArc mitochondrial target and our nuclear 
RNAseP, we were able to validate that the method we developed can accurately measure 
MtCopy in sperm samples. With the use of QuantStudio3D Digital PCR system by 
Thermofisher Scientific, absolute copy number in our qPCR was compared to dPCR. Figure 
5 represents the values achieved from each method for the eight samples. 
 
Figure 5. MtCopy Yields from Two Methods. Values from eight samples by 
using digital PCR and Triplex in qPCR. 
 
 
Figure 6 shows a scatter plot of MtCopy yields derived from the two methods shown with a 
line of linear model. Pearson correlation between dPCR and qPCR are comparable, given the 
high R2 value (rho>0.99; p-value <0.001). 
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Figure 6. dPCR and Triplex qPCR MtCopy yields 
 
4.6. Comparisons of Phthalate Metabolites 
4.6.1. SEEDS and CDC 
Figure 7 shows a comparison of urinary phthalate metabolite concentrations between 
two sources, after correction for dilution. The sources of data presented in the Figure 7 are 
the CDC Fourth report on human exposure to environmental chemicals from the National 
Health and Nutrition Examination Survey (NHANES) between 2011-2012 as well as the 
participants of the SEEDS study.  
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Figure 7. Comparison of Urinary Phthalate Metabolites from Two Sources. Figure shows 
thirteen total metabolites geometric means from SEEDS and NHANES. 
 
A comparison of 95% confidence intervals of geometric mean derived from 
NHANES data published by the CDC in addition to the SEEDS data for 103 individuals. 
Two metabolites, MHINCH and MCOCH, are excluded in the Figure 7 due to 
geometric means and 50th percentile falling below LOD for NHANES data. One metabolite, 
MHBP, was not provided in the CDC Fourth report and is not reported. Also, due to 
geometric means falling under LODs, the 50th percentile is shown for metabolites MNP and 
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MMP. Three metabolites have higher geometric means in SEEDS participants than in those 
reported by the CDC (MCNP, MBP, MIBP). 
4.6.2. Differences Among SEEDS individuals 
Mean concentrations of specific gravity corrected phthalate metabolite concentrations 
were evaluated for differences between fertile and infertile groups. Metabolites MBzP and 
MEP showed borderline significant differences between mean concentrations in fertile and 
infertile men (1.4 ± 1.1 ng/mL vs. 1.8 ± 1.0 ng/mL and p=0.074; 3.2± 1.3 ng/mL vs. 3.6 ± 1.0 
ng/mL and p=0.054, respectively) while MCNP was shown to be significantly higher among 
infertile men (1.0 ± 0.6 ng/mL vs. 1.3 ± 0.8 ng/mL and p=0.025). Both MtCopy and 
MtDeletion were found to be significantly lower in fertile men than in infertile males (1.8 ± 
1.1 vs. 6.2 ± 7.1 copies and p=0.005; 0.18 ± 0.09 vs. 0.23 ± 0.07 deletions and p=0.004, 
respectively). No differences were observed for specific gravity adjusted isoprostane 
concentrations between the two groups. Additionally, there were no differences between 
isoprostane concentrations or MtDeletion between smokers and non-smokers, while there 
was a borderline significant difference in means between the two for MtCopy (2.1 ± 0.8 vs. 
3.0 ± 4.3 copies and p=0.079), although the sample size of current smoking was only of eight 
individuals. 
 
4.7. Linear Regression Analyses 
4.7.1. MtCopy 
Table 6 presents beta estimates from adjusted linear regression models of changes in 
sperm MtCopy number associated with 1ng/mL concentration increase in urinary phthalate 
metabolite or isoprostane concentration. Models were adjusted by batch phthalate, batch 
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qPCR, age, BMI, and current smoking. Although DINCH metabolites show low percentages 
of detection, the two were still treated as other metabolites with respect to their log 
transformed SG adjusted value.  
Table 6. Effect estimates using generalized 
     linear regression for MtCopy (n=97) 
 Estimate (95% CI) p-value 
MEHP 0.29 (-0.82, 1.40) 0.61 
MEOHP -0.02 (-1.16, 1.13) 0.98 
MEHHP -0.17 (-1.29, 0.95) 0.77 
MECPP -0.12 (1.27, 1.03) 0.84 
MCOP 0.22 (-0.67, 1.11) 0.62 
MNP 0.31 (-0.77, 1.39) 0.58 
MBzP 0.36 (-0.50, 1.22) 0.42 
MCPP -0.24(-1.30, 0.83) 0.66 
MCNP 1.56 (0.16, 2.95) 0.03 
MBP 0.09 (-0.99, 1.16) 0.88 
MHBP -0.25(-1.60, 1.10) 0.72 
MiBP -0.29 (-1.40, 0.82) 0.61 
MHiBP -0.48 (-1.55, 0.59) 0.38 
MMP1 -0.11 (0.48, -1.06) 0.82 
MEP 0.11(-0.66, 0.87) 0.79 
MCOCH -0.26 (-1.39, 0.87) 0.65 
MHINCH -0.41 (-1.29, 0.48) 0.37 
IsoP -0.05 (-0.15, 0.04) 0.28 
Models adjusted for age, BMI, batch (qPCR; 
phthalate), 
and current smoking 
1Adjustment did not include batch phthalate (n=50) 
 
One metabolite, MCNP, was shown to be positively associated with MtCopy (=1.56 (0.16, 
2.95), p= 0.03). Figure 8 reflects the effect estimates shown in Table 6. Additionally, 
MtDeletion and MtCopy were found to be in significant correlation (Pearson rho=0.27; p-
value <0.008).  
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Figure 8. GLM Effect Estimates of MtCopy. Bars represent 95% confidence intervals (n=97) 
 
To further consider differences, models were stratified by fertility status. Although 
neither estimate for MCNP in stratified analyses were significant, both showed positive 
effect estimates (=0.345 (-0.15, 0.84) for fertile men; =2.59 (-1.75, 5.55) for infertile men), 
as shown in Table 7. In fertile men only, metabolites MNP and MCOP showed borderline 
significant positive associations with MtCopy. Neither in whole population nor stratified 
analyses was isoprostane found to be associated with MtCopy. Table 7 provides estimates of 
generalized linear regression models of stratified analyses for MtCopy. 
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Table 7. Stratified linear regression estimates of MtCopy. GLM estimates with 95% 
confidence intervals (CI) and significance of MtCopy in stratified analyses of SEEDS male 
individuals for Fertile (n=72) and Infertile (n=25) 
Fertile  Infertile  
 Estimate (95% CI) p-value  Estimate (95% CI) p-value 
MEHP 0.13 (-0.19, 0.45) 0.43 MEHP 2.33 (-2.97, 7.64) 0.4 
MEOHP -0.01 (-0.35, 0.33) 0.94 MEOHP -3.15 (-8.38, 2.07) 0.26 
MEHHP -0.04 (-0.37, 0.30) 0.84 MEHHP -2.21 (-6.98, 2.55) 0.38 
MECPP -0.03(-0.39, 0.32) 0.86 MECPP -2.50 (-6.81, 1.80) 0.27 
MCOP 0.24 (-0.03, 0.50) 0.08 MCOP 1.88 (-1.79, 5.55) 0.33 
MNP 0.29 (-0.03, 0.61) 0.08 MNP 0.22 (-4.46, 4.90) 0.93 
MBzP -0.15 (0.40, 0.10) 0.25 MBzP 0.78 (-3.15, 4.72) 0.7 
MCPP 0.23 (-0.12, 0.59) 0.2 MCPP -0.66 (-4.90, 3.57) 0.76 
MCNP 0.35 (-0.15, 0.84) 0.18 MCNP 2.59 (-1.75, 6.92) 0.26 
MBP <0.003 (-0.33, 0.34) 0.99 MBP 1.29(-3.52, 6.10) 0.61 
MHBP -0.01(-0.45, 0.43) 0.95 MHBP -0.99 (-8.03, 6.06) 0.79 
MiBP -0.05 (-0.41, 0.30) 0.77 MIBP -0.32 (-4.14, 3.49) 0.87 
MHiBP -0.02 (-0.36, 0.31) 0.89 MHIBP -0.36 (-5.08, 4.36) 0.88 
MMP1 -0.04 (-0.55, 0.46) 0.87 MMP1 -1.22 (-5.84, 3.40) 0.62 
MEP 0.10 (-0.12, 0.32) 0.4 MEP 0.068 (-3.91, 4.04) 0.97 
MCOCH -0.10 (-0.42, 0.22) 0.56 MCOCH 0.15 (-5.45, 5.76) 0.96 
MHINCH -0.12 (-0.39, 0.15) 0.38 MHINCH -0.34 (-3.99, 3.16) 0.86 
IsoP -0.02 (-0.16, 0.12) 0.78 IsoP -1.82 (-4.23, 0.58) 0.16 
Models adjusted for age, BMI, batch (qPCR; phthalate), and current smoking 
1Adjustment did not include batch phthalate 
 
4.7.2. MtDeletion 
Table 8 shows adjusted linear regression models of MtDeletion on phthalate 
metabolites and IsoP concentrations. Models are adjusted for age, BMI, batch phthalate, 
batch qPCR, and current smoking. No phthalate metabolite was found in significant 
association with MtDeletion. Additionally, isoprostane concentration was not associated with 
MtDeletion. Figure 9 reflects the effect estimates and 95% confidence intervals of Table 8. 
 
 
 
 
 
 33  
Table 8. Effect estimates using generalized 
linear regression for MtDeletion (n=97) 
 Estimate (95% CI) p-value 
MEHP 0.02 (-0.004, 0.043) 0.1 
MEOHP 0.002 (-0.023, 0.026) 0.9 
MEHHP 0.005(-0.020, 0.029) 0.71 
MECPP 0.003(-0.022, 0.027) 0.84 
MCOP 0.006 (-0.013, 0.025) 0.55 
MNP 0.011 (-0.012, 0.034) 0.35 
MBzP 0.007(-0.012, 0.025) 0.47 
MCPP 0.006 (-0.017, 0.029) 0.6 
MCNP 0.021 (-0.010, 0.051) 0.19 
MBP 0.015 (-0.008, 0.037) 0.21 
MHBP 0.015 (-0.014, 0.044) 0.3 
MiBP 0.014 (-0.010, 0.037) 0.26 
MHiBP 0.003 (-0.020, 0.026) 0.82 
MMP1 <-0.001(-0.037, 0.036) 0.96 
MEP 0.008 (-0.009, 0.024) 0.36 
MCOCH -0.004 (-0.028, 0.021) 0.78 
MHINCH -0.002 (-0.021, 0.017) 0.82 
IsoP 0.0002 (-0.010, 0.011) 0.96 
Models adjusted for age, BMI, batch (qPCR; 
phthalate), and current smoking 
1Adjustment did not include batch phthalate 
(n=50) 
 
 
Figure 9. GLM Effect Estimates of MtDeletion. Bars represent 95% confidence intervals 
(n=97) 
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In stratified analyses (Table 9), metabolite MEHP was shown to be positively associated with 
MtDeletion in only infertile men (=0.076 (0.029, 0.123); p= 0.006). Additionally, 
MtDeletion was not found in association with isoprostane in either analysis.  
Table 9. Stratified linear regression estimates of MtCopy. GLM estimates of MtDeletion on 
phthalates metabolites and IsoP in stratified analyses of Fertile (n=72) and Infertile (n=25) 
SEEDS participants 
Fertile  Infertile  
 Estimate (95% CI) p-value  Estimate (95% CI) p-value 
MEHP 0.015 (-0.011, 0.041) 0.26 MEHP 0.076 (0.029, 0.123) 0.006 
MEOHP <-0.001 (-0.029, 0.027) 0.95 MEOHP -0.012(-0.072, 0.049) 0.7 
MEHHP 0.001 (-0.026, 0.029) 0.92 MEHHP 0.002(-0.052, 0.057) 0.93 
MECPP -0.003 (0.032, 0.026) 0.82 MECPP 0.007(-0.042, 0.057) 0.77 
MCOP 0.008 (-0.014, 0.030) 0.49 MCOP 0.022 (-0.018, 0.063) 0.3 
MNP 0.013 (-0.013, 0.040) 0.34 MNP 0.013 (-0.038, 0.065) 0.62 
MBzP 0.005 (-0.016, 0.026) 0.64 MBzP -0.007 (-0.051, 0.037) 0.76 
MCPP 0.013 (-0.016, 0.043) 0.37 MCPP 0.005 (-0.042, 0.053) 0.83 
MCNP 0.015 (-0.026, 0.057) 0.47 MCNP 0.019 (-0.031, 0.068) 0.47 
MBP 0.011 (-0.017, 0.038) 0.46 MBP 0.036 (-0.015, 0.087) 0.19 
MHBP 0.013 (-0.023, 0.049) 0.49 MHBP 0.006 (-0.073, 0.085) 0.88 
MiBP 0.016 (-0.014, 0.045) 0.3 MIBP -0.003 (-0.046, 0.040) 0.89 
MHiBP 0.004 (-0.024, 0.031) 0.8 MHIBP -0.025 (-0.076, 0.026) 0.35 
MMP1 -0.006 (-0.046, 0.034) 0.78 MMP1 -0.022(-0.121, 0.077) 0.67 
MEP 0.011 (-0.007, 0.029) 0.24 MEP -0.031 (-0.072, 0.011) 0.17 
MCOCH <-0.001 (-0.027, 0.026) 0.98 MCOCH -0.029 (-0.090, 0.032) 0.37 
MHINCH 0.003 (-0.019, 0.025) 0.81 MHINCH -0.026 (-0.065, 0.013) 0.21 
IsoP 0.002 (-0.009, 0.013) 0.72 IsoP -0.021 (-0.048, 0.006) 0.14 
Models adjusted for age, BMI, batch (qPCR; phthalate), and current smoking 
1Adjustment did not include batch phthalate 
 
4.7.3. Isoprostane 
Seven metabolites were found in association with isoprostane in adjusted linear 
regression analyses, as shown in Table 10 (MEOHP, MEHHP, MBzP, MBP, MHBP, MiBP, 
MHiBP). All of the seven associations displayed a positive relationship with IsoP. Figure 10 
reflects effect estimates shown in Table 10. 
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Table 10. GLM Effect Estimates for IsoP.  Estimates reflect urinary phthalate metabolites in 
SEEDS male partners (n=101) 
Metabolite Beta (95% CI) p-value 
MEHP 0.35 (-0.14, 0.84) 0.16 
MEOHP 0.67 (0.18, 1.16) 0.008 
MEHHP 0.54 (0.06, 1.03) 0.03 
MECPP 0.34 (-0.15, 0.86) 0.17 
MCOP 0.03 (-0.37, 0.42) 0.89 
MNP -0.05 (-0.54, 0.43) 0.82 
MBzP 0.40 (0.02, 0.78) 0.04 
MCPP 0.18 (-0.29, 0.66) 0.45 
MCNP 0.03 (-0.61, 0.67) 0.93 
MBP 0.62 (0.16, 1.07) 0.01 
MHBP 0.63 (0.05,1.22) 0.04 
MiBP 1.04 (0.60, 1.47) <0.001 
MHiBP 0.85 (0.41, 1.29) <0.001 
MMP1 0.32 (-0.33, 0.96) 0.34 
MEP 0.09 (-0.25, 0.43) 0.6 
MCOCH -0.07 (-0.57, 0.44) 0.79 
MHINCH 0.32 (-0.07, 0.71) 0.11 
Models adjusted for age, BMI, batch (qPCR; phthalate), 
and current smoking 
1Adjustment did not include batch phthalate 
 
 
Figure 10. GLM Effect Estimates (95% CI) of IsoP 
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4.8. Logistic Regression Analyses 
Because odds ratios for infertility were positively associated with both MtCopy and 
MtDeletion in adjusted logistic regression analyses for age, BMI, batch, and current smoking, 
odds ratios of infertility by both quartile of MtCopy and quartile of MtDeletion were 
investigated. The odds ratios of infertility was borderline significant and significant for the 
third (OR=7.65 (1.15, 14.15), p= 0.08) and fourth (OR=69.69 (63.09, 76.38), p= <0.001) 
quartile of MtCopy. An odds ratio of infertility was significant for the fourth quartile of 
MtDeletion (OR=7.72 (3.00, 12.44), p= 0.02). The relationship between IsoP and odds of 
infertility did not reach significance. Figure 11 and Figure 12 reflect the odds ratios of 
infertility by quartile of MtCopy and MtDeletion. Additionally, the following tables reflect 
Fertility Status by Quartile of MtCopy (Table 11) or by Quartile of MtDeletion (Table 12). 
 
 
Figure 11. Odds Ratios of Infertility by Quartile of MtCopy 
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Figure 12. Odds Ratios of Infertility by Quartile of MtDeletion 
Table 11. Fertility Status by Quartile of MtCopy 
Quartile Fertile Infertile Total 
1 23 2 25 
2 21 3 24 
3 19 5 24 
4 9 15 24 
 
Table 12. Fertility Status by Quartile of MtDeletion 
Quartile Fertile Infertile Total 
1 22 3 25 
2 21 3 24 
3 15 9 24 
4 14 10 24 
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CHAPTER 5 
DISCUSSION 
5.1. Trends in Phthalate Metabolites in our Population 
Highest concentrations of phthalate metabolites of the seventeen include MEP, 
MECPP, and MCOP. Although the trend over the past decade has been downward for the 
former two metabolites, MCOP has steadily increased. With the exception of two phthalates, 
MNP and MEP, the highest concentrations of all phthalate metabolites are observed in the 
youngest population aged 6-11 years old according to data from the CDC. MEP had one of 
the highest concentrations in our study, and individuals over the age of 20 are shown to have 
the highest levels compared to different age groups. After urinary dilution correction only 
two metabolites, MNP and MMP, are shown to be higher in males than females according to 
NHANES date, although statistical differences are not known. Comparing geometric mean 
values in our study to NHANES derived phthalate metabolite concentrations, MCNP, MBP, 
and MiBP were shown to be higher in our sample of 102 individuals. MCNP, a metabolite of 
DiDP, has been shown to fluctuate in its trend, as NHANES data reflects both increases and 
decreases over the past decade. According to updated tables of 2011-2012, MCNP is among 
one of only two metabolites in which caucasians are shown to have the highest 
concentrations compared to other ethnicities. Considering the racial makeup of our 
population from those who responded in the questionnaire, this may not be surprising 
because most identify as white. Metabolites MnBP and MiBP, both of the parent compound 
DBP, are higher in our population although the trend has been shown to be increasing for 
only MiBP in a larger national sample.  
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5.2. Consistencies with other studies and Potential Pitfalls 
When comparing our urinary IsoP to those of other studies, it is important to consider 
discrepancies between methods as well as manufactured ELISA assays. Concentrations of 
isoprostane and phthalates in our study were corrected by specific gravity and not creatinine. 
Our method has been considered to be favorable in dilution correction of urine in studies of 
biological monitoring (Sauve JF et al 2015), however correction differences limit our ability 
to make direct comparisons of our values to others reported. Lastly, the presence of 
isoprostane is not believed to be cause of disease but rather a consequence of the oxidative 
stress. 
Our MtCopy numbers were fairly consistent with others reported. Other studies using 
real-time PCR reported a range and average MtCopy similar to values yielded in this assay, 
in a similar population consisting of some infertile men (May-Panloup et al 2003). It is 
promising that our results from logistic regression showing highest quartile of MtCopy is 
positively associated with odds of infertility considering that most studies report findings that 
suggest men with abnormal sperm have a higher MtCopy number compared to their normal 
sperm (Kao et al 2004; Gabriel MS et al 2012). Considering male factor infertility is 
determined by semen parameters, these findings are in line with more recent studies that have 
evaluated MtCopy number and sperm count and motility in a larger sample (Zhang G et al. 
2016).  
The method of DNA extraction has been shown to alter MtCopy number. One study 
has indicated that the method of DNA extraction can affect the calculation of relative 
MtCopy using a qPCR approach (Guo W et al., 2009). The QIAmp DNA Mini Kit was 
shown to recover approximately 78% of both mitochondrial DNA and nuclear DNA in tested 
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DNA of mouse liver cells and was used with the samples in our study. The QIAmp DNA kit 
showed improved mtDNA: nDNA ratios than the other tested column-based silica assay and 
performed comparable to isolation using phenol-chloroform/isoamyl alcohol extraction 
method (PCIAA) method, which yielded approximately 85% of the two DNA types. Future 
studies should take into account DNA extraction methods so measurement can most precisely 
portray these outcomes. 
All urinary analyses are performed on spot urine samples taken at the same time as 
semen procurement and oocyte retrieval. A number of studies have determined that urinary 
phthalate metabolites profiles may be consistent with a three-month period of time or longer 
(Townsend MK et al. 2013; Christensen KL et al. 2012; Hauser R et al. 2004; Teitelbaum SL 
et al. 2008). Also, longer chain phthalates including DEHP, DiBP, and DiDP may not have as 
long temporal stability as those with shorter chains such as DBP, DEP, DiBP, and BBzP 
(Johns LE et al 2015). In our study the sperm used for all assisted reproductive technologies 
is taken at the same time of urine collection and is indicative of the same period of one’s 
recent phthalate exposure and spermiogenesis. Additionally, our biomarker of oxidative 
stress F2t-isoprostane is shown to have a short half-life of approximately 16 minutes 
(Kaviarasan S et al 2009) which also is reflective of recent exposure of phthalates.  
 
5.3. Metabolites of Interest 
MCNP, Monocarboxy-isononly phthalate, is a metabolite of the high molecular 
weight parent compound Di-isodecyl phthalate (DiDP). The parent compound is mostly used 
in construction products in home dwellings, consumer products, and clothing 
(Saravanabhavan G and J Murray 2012). It is also shown to be similar to DINP, and the two 
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are often used interchangeably in industrial products as a replacement for DEHP. The 
secondary oxygenated metabolites are shown to yield higher urinary excretion concentrations 
than the monoester metabolite. Estimates of average daily intake in the United States is 
<1ug/kg/day across numerous age, race, and gender subsets. Based on the lowest found 
NOAEL of this compound, the tolerable daily intake of 150ug/kg/day is used by regulatory 
Consumer Product Safety Commission (Kransler KM et al 2013). The study used in 
derivation of the NOEAL used for this guideline was performed on three male and female 
dogs, for assessment with organ weights and histology in subchronic study (Hazelton, 1968). 
Overall little evidence suggests that DiDP is antiandrogenic. One study by Exxon Mobil, a 
producer of DiDP, found in all dose groups had lower percent of normal sperm in male rats 
(Exxon Mobil 1997), at doses ranging from 103 to 361 mg/kg body weight per day. In our 
study, estimates of intake would be two orders of magnitude less than the tolerable daily 
intake, and yet we are seeing effects at these low doses. Additionally, little evidence of 
induction of oxidative stress exists for this parent compound. In assessment of ear tissue 
homogenate of mice orally given 200mg/kg/day of DIDP, significant increases in ROS 
production and decreases in glutathione were observed (Shen S et al. 2016). 
Sperm parameters are used as a proxy of infertility. In our population, the hospital 
determines male factor fertility status. In our study, mean concentrations of three phthalate 
metabolites concentrations were found to be different between men considered fertile and 
infertile. In linear regression analyses of the entire population, MCNP was shown to be 
associated with MtCopy number in our SEEDS population. Although the relationship did not 
maintain statistical significance in stratified analyses, this could be due to loss of power due 
to small sample size. Because the effect estimates were both positive, it is an indication that 
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the relationship may be appreciable. Although stratifying was performed by fertility to see 
effect estimates, analyses were not adjusted by fertility status. Although it is possible that 
phthalate exposure and mitochondrial targets are both related to infertility, it would not be 
appropriate to adjust for infertility status because it is not expected that infertility would 
predate mitochondrial proliferation or phthalate exposure along a temporal sequence. Control 
for fertility status in regression models could introduce a bias. Stratification allows us to 
make guesses about phthalate exposure and mitochondrial outcomes on fertility status but 
would not induce an association between its causes.  
 
5.4. Systemic Isoprostane and Relation to Sperm MtCopy 
In this study, we also assessed urinary isoprostane, which is considered to be a gold 
standard in evaluation of systemic oxidative stress partially owing to the low-lipid content in 
urine. However, because seminal isoprostane was not assessed, the extent to which lipid 
peroxidation takes place on local conditions in the male germ cell or reproductive organs 
remains unclear. Because semen is known to have a high lipid content, it is especially 
susceptible to oxidative injury by lipid peroxidation (Moazamian R et al 2015). It was shown 
that men with normospermatic men have lower poly-unsaturated fatty acids than those with 
asthenozoosperm and may therefore be more vulnerable to lipid peroxidation (Calamera J et 
al., 2003). No known studies have established the relationship between levels of seminal 
isoprostane and urinary isoprostane. Urinary isoprostane continues to be recognized for its 
stability over time and its ability to represent chronic oxidative stress. For this reason, 
temporal sequence of oxidative stress and infertility can be reasoned. Additionally, infertile 
and fertile males in this study were not shown to have significant differences in 
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concentrations of isoprostane. Previous studies have shown that seminal free isoprostane 
concentrations were higher in men with seminal parameter abnormities, however their study 
size was small and we measured systemic oxidative stress in urine and not semen (A 
Khosrowbeygi and N Zarghami 2007). This same study showed that men with abnormal 
sperm had higher levels of polyunsaturated fatty acids, namely docosahexaenoic acid (DHA), 
and this was positively associated with mitochondrial ROS generation (Koppers AJ et al. 
2010). Isoprostanes are formed by the autooxidation of arachidonic acid, which we used in 
this study to assess systemic oxidative stress. Perhaps associations between sperm MtCopy 
and sperm specific targets of lipid peroxidation such as DHA, a known main target in sperm, 
would be more appropriate to assess this relationship (RJ Aitken et al. 2014). However 
conditions that lead to sperm specific oxidative stress and systemic oxidative stress are not 
mutually exclusive, considering exposures such as phthalates are shown to increase oxidative 
stress in a number of different cell types.  
Phthalates have been shown to induce apoptosis by reduction of enzymes necessary in 
antioxidant defense. Because disruption of apoptosis may influence spermiogenesis, it has 
been hypothesized that oxidative stress mediates this relationship. Additionally, it is 
theorized that dysfunction of mitochondria lead to issues with the mitochondrial membrane 
potential and in intracellular balance of proteins that regulate apoptosis (Fu G et al 2016; 
Dunn JD et al. 2015). Mitochondria in sperm have been shown to increase ROS generation. 
Apoptosis has been found in close association to increases in lipid peroxidation (Hamilton 
TR et al. 2016), and decreases in catalase and glutathione peroxidase (Madhubabu G et al. 
2014). Additionally, mitochondria are considered potential targets of EDCs (Xia W et al., 
2014), which have been shown to lead to decreased ATP production (Lin Y et al., 2013). 
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Mitochondrial injury can be the result of disturbances in the respiratory chain which lead to 
aberrations in controlled apoptosis (Fu G et al., 2017; Kaur K et al., 2014). Sperm apoptosis 
can result under conditions of oxidative stress, and the ability for phthalates to lead to 
apoptosis and increases in ROS has been documented in testicular cells (Shen H et al., 2015; 
Yang J et al., 2012; Alam MS et al., 2016) and germ cells (Erkekoglu P et al., 2012) and in 
humans (Wang XY et al., 2016). MtDeletion and MtCopy are both indicative of defected 
mitochondria, which may result from increases in ROS from the presence of phthalates. The 
result of the failure to eliminate mitochondria could be influencing apoptosis of sperm and 
therefore inducing issues with fertility. 
To our knowledge, this is the first study to examine both relative mitochondrial copy 
number and deletions in a triplex reaction using TaqMan probes in sperm of men of this 
population, and the first to look at these parameters in reference to phthalate concentrations. 
While a number of studies have investigated sperm parameters including concentration, 
motility, and total volume in infertile men, only one has looked at the relationship to 
mitochondrial copy number and a class of environmental pollutants. In a recent cross 
sectional study of 666 males, significant percent decreases in mitochondrial copy number 
were found in association with increases in four urinary PAH metabolites (Ling X et al. 
2017). Although more evidence is available to suggest increased MtCopy with poor 
reproductive outcomes, decreases in mtDNA content have been found in men with 
asthenospermia or <20% motility, compared to those with normal sperm (Kao SH et al. 
2004). In our study there is evidence that there is no optimal range of MtCopy, as there is 
evidence that the higher the value, the more evidence of higher odds of infertility.  
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The exact process of mtDNA elimination in sperm over spermiogenesis and up until 
fertilization remains unclear. Spermatozoa are believed to have between 22 and 80 
mitochondria per cell (St. John JC et al., 2000) and about 2-10 copies of mtDNA are 
predicted per mitochondrion (Rajender S et al., 2010). There is some indication that the 
mitochondrial membrane potential allows for selection of the most degraded mitochondria to 
be eliminated. By the time of implantation, paternal mtDNA are believed to be almost 
completely degraded (Song WH et al., 2014).  During disruption or damage mitochondria 
may undergo mitophagy, or selective removal. Under physiological circumstances changes in 
fission, fusion, shape, and localization allow mitochondria to respond to changes and self-
eliminate (Song WH et al., 2014). A controlling factor that regulates MtCopy throughout 
spermiogenesis is mitochondrial transcription factor activator mtTFA. TFAM aids in 
protecting mtDNA from injuries of oxidative phosphorylation and it is down regulated 
throughout the process (Rajender S et al., 2010).  Because sperm may be especially 
vulnerable to oxidative injury, it could be biologically beneficial to have decreased MtCopy 
in sperm that can be damaged by ROS (Rajender S et al., 2010). Additionally, optimal sperm 
mtDNA thresholds have been theorized (Wai T et al., 2010) although undetermined. Ten men 
in our study had MtCopy higher than five, and nine of those individuals were infertile. 
Gradient centrifugation was used to isolate motile sperm and therefore discern the best 
quality sperm for use in ART; despite this, we still found positive associations with 
infertility. This may be suggestive that MtCopy less than five is optimal. In our study, we 
found indications of phthalate associated oxidative stress but we did not find a relationship 
between MtCopy and phthalates or MtCopy and systemic oxidative stress. It could be that a 
relationship between MtCopy and MtDeletion with oxidative stress was missed in our study 
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population due to our biomarker. Although it has been evidenced that increases in ROS 
impact MtCopy and MtDeletion, the control of mitochondrial elimination may be more 
tightly controlled in sperm. In sperm MtCopy and MtDeletion does not seem to be a 
representative biomarker for systemic oxidative stress and phthalate exposure is not shown to 
be associated these measurements. 
 
5.5. Future Directions 
Further investigation shall include the use of inflammatory markers and potentially 
the measurement of isoprostane in semen to consider the potential relationship. Additionally, 
the relationship between these mitochondrial outcomes to sperm parameters and phthalates to 
sperm parameters will be further assessed. A future direction will also be to examine into 
developmental outcomes and embryo quality. 
 
5.6. Conclusions 
Because phthalates are ubiquitous, the public health relevance of this research is 
clear. Indications of perturbations in sperm mitochondria have reproductive health 
implications, as the ability to recognize associations with sperm quality can affect overall 
health. An understanding of mitochondrial copy number and integrity are novel tools in 
determinations of male infertility. Although this study did not find associations between 
oxidative stress, it could be owing to the unique and complicated nature of sperm. It is fairly 
evident from this research that phthalates may not be impacting the failure to eliminate 
mitochondria or the deletion proportion. Another potential mediator between phthalate 
exposure and mitochondria in sperm could have been missed. This approach is especially 
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relevant to understanding the role of oxidative stress in the body, in accompaniment with a 
well-established biomarker of oxidative stress, during the time of preconception. This study 
is particularly innovative because it is the only study to simultaneously quantify 
mitochondrial copy and mitochondrial deletions in human sperm to examine associations 
with both urinary phthalate concentrations in a fertility setting.  
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APPENDIX I 
PILSNER LAB PROTOCOL FOR RELATIVE QUANTIFICATION 
Sperm Mitochondrial Copy and Deletion Relative Quantification 
Equipment and Materials Needed 
  StepOnePlus Real-Time PCR System (Applied Biosystems # 4376600) 
  StepOne Software v2.3 (Applied Biosystems) 
  NanoDrop2000 UV-Vis Spectophotometer (ThermoFisher Scientific) 
  Lowbinding 1.5mL tubes 
Reagents 
  TaqMan RNAseP Assay VIC-QSY 20x(Applied Biosystems # A30064) 
  TaqPath ProAmp Master Mix (Applied Biosystems # A30865) 
  IDTE Buffer pH 8.0 (1x TE Solution) (IDT #11-01-02-05) 
  Nuclease Free Water 
 
Primer Sequences 
  FWD MinorArc: 5’- CTA AAT AGC CCA CAC GTT CCC-3’ 
  REV MinorArc: 5’- AGA GCT CCC GTG AGT GGT TA-3’ 
  FWD MajorArc: 5’-CTG TTC CCC AAC CTT TTC CT-3’ 
  REV MajorArc: 5’-CCA TGA TTG TGA GGG GTA GG-3’ 
Probe Sequences 
  MinorArc: 6FAM-CAT CAC GAT GGA TCA CAG GT-MGBNFQ 
  MajorArc: NED- GAC CCC CTA ACA ACC CCC-MGBNFQ 
 
A. Sperm DNA Preparation and Dilution 
(If sperm is already diluted, skip to Part B.) 
1. Isolate DNA using Qiagen AllPrep Kit via Pilsner lab protocol (Wu et al 2015) 
2. Determine concentration of DNA using NanoDrop system 
3. Dilute sperm DNA to ~5ng/ul using C1V1=C2V2. If sample is below 5ng/ul, do not 
dilute sample. 
 
B. Standard Curve Preparation 
1.    Remove 3ul of sperm from each sample and combine into 1.5mL low binding tubes. 
Vortex. 
2.    Determine concentration on NanoDrop of combined sample. 
3.    Label tubes Standard 1-6. Add 50ul of TE Buffer to tubes labeled Standards 2-6. Add 
50ul of Standard 1 into Standard 2. Repeat 1:1 Serial Dilutions. Keep Standards in 
4C. 
 
C. Reagent Preparation  
Before starting: MasterMix should be kept in 4C. All primers and probes may be kept at 4o C 
for up to ten weeks or may go through up to ten freeze thaw cycles. Keep stocks in -25C. 
1. Dilute MinorArc probe to 5uM from its stock concentration of 100uM. For example, 
create 5uM probe mix for a 300ul final volume by adding 285ul of TE Buffer 8.0 
with 15ul of the probe stock. Vortex for 30 seconds.  
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• Repeat step 1 for MajorArc 
2. Create a Primer Mix at 5uM for MinorArc with each of its Forward and Reverse 
primer stocks at a concentration of 100uM. For example, create 5uM primer mix for a 
300ul final volume by adding 270ul of TE Buffer 8.0 with 15ul of the MinorArc 
Forward Primer Stock and the MinorArc Reverse Primer Stock. Vortex for 30 
seconds.  
• Repeat step 2 for MajorArc 
3. Plan Super Master Mix depending on the number of samples being run. In every 10ul 
reaction, total volumes of each reagent are included on the following table: 
 
Reagents Volume  
FAM labeled MinorArc Probe at 5uM 0.5uL 
MinorArc Primer Mix at 5uM 0.5uL 
NED labeled MajorArc Probe at 5uM 0.5uL 
MajorArc Primer Mix at 5uM 0.5uL 
VIC labeled RNAseP Primer/Probe Mix at 20x 0.5uL 
Nuclease-free H2O 0.5uL 
ProAmp 2x Master Mix 5uL 
~5ng/ul DNA template 2uL 
 
• For a 96-well plate with 20% error, combine 576ul Master Mix with 57.5ul of 
all reagents (excluding DNA) 
4. Prepare plate by adding 8ul of Super Master Mix (not containing DNA) to each 
empty well. 
5. Pipette 2ul of ~5ng/ul DNA into each well containing Super Master Mix; combine by 
pipetting up and down.  
6. Prepare plate to have all standards and samples in triplicate reactions wells. 
7. Centrifuge plate at low speed for as long as necessary to remove large bubbles. 
 
D. StepOne System 
1. Open the StepOne software to begin a new experiment and select Advanced Setup 
2. Use Quantification-Standard Curve as experiment type, TaqMan Reagents for target 
sequence reagents, and Standard(~2 hours to complete run) for ramp speed. 
3. Define three targets using MinorArc with Reporter FAM and Quencher NFQ-MGB, 
MajorArc with Reporter NED and Quencher NFQ-MGB, and RNAseP with Reporter 
VIC and Quencher None. 
4. Define samples. 
5. Under Run Method: Set Holding Stage for 10:00 at 95C, and 40 Cycles of 95C for 15 
seconds, 55C for 15 seconds, and 60C for 60 seconds. 
6. Once Run is complete, Go to Analysis Settings. Under CT Settings, deselect “Use 
Default Settings” and set the Thresholds as: 0.1 for RNAseP, 0.1 for MinorArc, and 
0.05 for MajorArc. Apply new Analysis Settings.  
7. If Standard Deviation is greater than 0.5 for any of the three targets among triplicate 
samples, identify and eliminate well that produces high Standard Deviation. 
Additionally, if CV% is higher than 15 for triplicate samples, eliminate one of the 
wells and use only duplicate sample measurements. 
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E. Standard Curve Calculations 
1. Linearity 
• Plot the standard curve with average CT of triplicate wells for each target on 
the Y-axis and log DNA added to each reaction on the X-axis. Add trend line 
to each target across standards and add R2 values. R2 values are considered 
acceptable at >0.99.  
2. Slope 
• The amplification efficiencies of each target may be calculated using the slope 
of each trend line across standards. The formula for efficiency of each target is 
calculated by the following formula: E=10^(-1/slope), where the slope is 
calculated across all standard. Amplification efficiencies are considered 
acceptable between 90-105%. 
 
F. Mitochondrial Copy Number and Deletion Calculation 
1. For each reaction per well, use the following formula to determine Mitochondrial 
Copy (MtCopy): 
• 2^(meanCT), where CT=(RNAseP CT- MinorArc CT) 
• CT differences are found per reaction and averages were based on CTs from 
triplicate measurements 
2. For each reaction per well, use the following formula to determine Mitochondrial 
Deletions (MtDeletion): 
• 2^(meanCT), where CT=(MinorArc CT- MajorArc CT) 
• CT differences are found per reaction and averages were based on CTs from 
triplicate measurements 
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APPENDIX II 
PARENT PHTHALATE DIESTER AND ALTERNATIVE STRUCTURES 
HMW  
      
i. Di(2-ethylhexyl) phthalate (DEHP)          ii. Diisononyl phthalate (DINP) 
C28H38O4                                  C26H42O4 
 
 
 
                    
iii. Benzyl butyl phthalate (BzBP)             iv. Dioctyl Phthalate (DOP) 
C19H20O4                                  C24H34O8
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v. Diisodecyl phthalate (DIDP) 
C28H46O4 
 
LMW 
                                          
i. Di-n-Butyl phthalate (DBP)                           ii. Di-iso-butyl Phthalate (DiBP) 
C16H22O4                                             C16H22O4
  
                                                                                
iii. Di-methyl phthalate (DMP)                       iv. Di-ethyl Phthalate (DEP) 
C10H10O4                                             C12H14O4 
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Phthalate Alternative 
 
i. Di-isononyl cyclohexane-1,2-dicarboxylate(DiNCH) 
C26H48O4 
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